BenevolentAI Collaborates with UC San Diego to Develop Non-Invasive Therapies for Cerebral Cavernous Malformations

 BenevolentAI Collaborates with UC San Diego to Develop Non-Invasive Therapies for Cerebral Cavernous Malformations

BenevolentAI Collaborates with UC San Diego to Develop Non-Invasive Therapies for Cerebral Cavernous Malformations

Shots:

  • BenevolentAI will utilize its ML and data science models to identify new genes responsible for the development and progression of CCM, for which brain surgery is the only treatment option for the patients
  • The collaboration is supported by the Angioma Alliance charity and funded by the Be Brave for Life Foundation and will have the direct impact on CCM pathogenesis with the potential to reduce the lifelong risk of stroke in CCM patients
  • The agreement integrates bioinformatics, AI-based technology, and experimental models to inform aspects of human cardiovascular cell-biology and disease directly

Click here ­to­ read full press release/ article | Ref: BenevolentAI | Image: HBS Digital Initiative

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post